fluorobenzenes has been researched along with Thyroid Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cleland, JG; Gullestad, L; Jhund, PS; Kjekshus, J; McMurray, JJ; Perez, AC; Stott, DJ; van Veldhuisen, DJ; Wikstrand, J | 1 |
1 trial(s) available for fluorobenzenes and Thyroid Diseases
Article | Year |
---|---|
Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure).
Topics: Aged; Analysis of Variance; Biomarkers; Drug Administration Schedule; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptides; Pyrimidines; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Thyroid Diseases; Thyrotropin; Treatment Outcome | 2014 |